| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 9.865 | 32.320 | 25.839 | 12.543 | 20.812 | 5.870 | 0 | 0 | 0 |
| Total Income - EUR | - | 9.865 | 32.320 | 25.839 | 12.543 | 20.812 | 5.870 | 0 | 0 | 0 |
| Total Expenses - EUR | - | 9.127 | 34.529 | 25.378 | 19.269 | 23.221 | 12.191 | 342 | 96 | 113 |
| Gross Profit/Loss - EUR | - | 738 | -2.209 | 461 | -6.726 | -2.409 | -6.321 | -342 | -96 | -113 |
| Net Profit/Loss - EUR | - | 537 | -2.532 | 202 | -6.851 | -2.600 | -6.379 | -342 | -96 | -113 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Bioliv Activ Forte Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 94 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 3.410 | 6.697 | 3.015 | 3.612 | 3.232 | 207 | 231 | 270 | 270 |
| Inventories | - | 78 | 366 | 384 | 283 | 1.770 | 70 | 70 | 70 | 70 |
| Receivables | - | 501 | 5.713 | 0 | 2.889 | 69 | 129 | 175 | 175 | 194 |
| Cash | - | 2.831 | 618 | 2.631 | 440 | 1.393 | 8 | -15 | 25 | 7 |
| Shareholders Funds | - | 581 | -1.961 | -1.723 | -8.540 | -10.979 | -17.114 | -17.510 | -17.552 | -17.567 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.922 | 8.658 | 4.738 | 12.153 | 14.210 | 17.322 | 17.740 | 17.823 | 17.837 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Bioliv Activ Forte Srl